Elizabeth Nedjoika, | |
98-939 Moanalua Rd, Aiea, HI 96701-5012 | |
(855) 223-7123 | |
Not Available |
Full Name | Elizabeth Nedjoika |
---|---|
Gender | Female |
Speciality | Behavior Technician |
Location | 98-939 Moanalua Rd, Aiea, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396304903 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
106S00000X | Behavior Technician | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth Nedjoika, 16782 Von Karman Ave Ste 11, Irvine, CA 92606-2417 Ph: (855) 223-7123 | Elizabeth Nedjoika, 98-939 Moanalua Rd, Aiea, HI 96701-5012 Ph: (855) 223-7123 |
News Archive
Results from a 10-year study suggest two strains of influenza that could mix and form a dangerous new strain of influenza spread by dogs.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 7,790,217 entitled "Method of Attaching an Antimicrobial Cationic Polyelectrolyte to the Surface of a Substrate."
LiveData and KARL STORZ Endoscopy- America, Inc. today announced that East Cooper Medical Center will install the companies' Patient-Aware OR solution in the eight operating rooms in East Cooper's new hospital to be opened this quarter. KARL STORZ is a global leader in minimally invasive endoscopic technologies and operating room integration. LiveData is a leader in real-time data integration and display technology.
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
› Verified 1 days ago